RCEL vs. ANGO, UTMD, TLSI, INO, SGHT, PROF, GUTS, OBIO, CVRX, and ARAY
Should you be buying AVITA Medical stock or one of its competitors? The main competitors of AVITA Medical include AngioDynamics (ANGO), Utah Medical Products (UTMD), TriSalus Life Sciences (TLSI), Inovio Pharmaceuticals (INO), Sight Sciences (SGHT), Profound Medical (PROF), Fractyl Health (GUTS), Orchestra BioMed (OBIO), CVRx (CVRX), and Accuray (ARAY). These companies are all part of the "surgical & medical instruments" industry.
AngioDynamics (NASDAQ:ANGO) and AVITA Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, community ranking, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.
AngioDynamics has a beta of 0.67, meaning that its stock price is 33% less volatile than the S&P 500. Comparatively, AVITA Medical has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500.
AngioDynamics received 289 more outperform votes than AVITA Medical when rated by MarketBeat users. However, 68.57% of users gave AVITA Medical an outperform vote while only 60.67% of users gave AngioDynamics an outperform vote.
AVITA Medical has lower revenue, but higher earnings than AngioDynamics. AVITA Medical is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks.
AngioDynamics currently has a consensus target price of $14.25, indicating a potential upside of 133.22%. AVITA Medical has a consensus target price of $27.80, indicating a potential upside of 226.67%. Given AngioDynamics' higher probable upside, analysts clearly believe AVITA Medical is more favorable than AngioDynamics.
AngioDynamics has a net margin of -60.21% compared to AngioDynamics' net margin of -70.56%. AVITA Medical's return on equity of -3.48% beat AngioDynamics' return on equity.
In the previous week, AngioDynamics and AngioDynamics both had 4 articles in the media. AVITA Medical's average media sentiment score of 1.25 beat AngioDynamics' score of 0.55 indicating that AngioDynamics is being referred to more favorably in the media.
89.4% of AngioDynamics shares are held by institutional investors. Comparatively, 27.7% of AVITA Medical shares are held by institutional investors. 5.1% of AngioDynamics shares are held by company insiders. Comparatively, 1.8% of AVITA Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
AngioDynamics beats AVITA Medical on 10 of the 16 factors compared between the two stocks.
Get AVITA Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RCEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AVITA Medical Competitors List
Related Companies and Tools
